Masimo (MASI) is back in focus after recent trading left the shares around US$138.92, with returns that differ sharply across time frames, from a small move over the past month to a deeper decline ...
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks ...
Investors looking for stocks in the Medical - Instruments sector might want to consider either Fresenius (FMS) or Masimo ...
Apple was at risk of having imports of all Apple Watches halted because of an ongoing legal dispute. Here’s what happened.
Mixed bag of news for Apple as Masimo tumbles in quality despite patent win, on-device AI threatens data centers, and the Tim ...
Masimo Corporation (NASDAQ:MASI) is one of the best NASDAQ stocks to buy in 2026. On December 5, Wells Fargo raised the ...
Masimo (Nasdaq: MASI) is a global technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, ...
Medical device company Masimo has accused Apple of patent infringement, filing a complaint against the company with the U.S. International Trade Commission yesterday. Bloomberg, which first spotted ...
Masimo CEO Joe Kiani, whose medical-technology company is in the midst of a proxy battle with activist Politan, revealed what he called confidential information to a major investor 12 hours before it ...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
Masimo’s first entry in the consumer smartwatch space, the W1, which launched last summer, boasts second-by-second readings of oxygen saturation, pulse rate, respiration rate, hydration index and more ...
Masimo reported positive Q4 results. However, investors weren't happy with the company's plan to acquire Sound United. The concerns center on whether Sound United, a consumer tech company, is a good ...